Pharmacists have been saving lives and improving patient outcomes for decades, but much of that value remains invisible to CMS, payers, and the broader healthcare system.
Every day, pharmacists identify dangerous interactions, optimize medication therapy, prevent medication-related harm, improve adherence, and help patients avoid hospitalizations and readmissions. Yet many of these interventions never become measurable data that follows the patient or demonstrates what the pharmacist prevented.
Could artificial intelligence finally change that?
Dr. Michael Hogue, Executive Vice President and CEO of the American Pharmacists Association, joins RxRewired to discuss how AI could connect pharmacist interventions to patient outcomes and make their clinical value impossible to ignore.
In Part One, we explore:
• Whether pharmacists should be afraid of AI
• Why pharmacists’ clinical value often remains invisible to CMS and payers
• Using AI to connect pharmacist interventions with patient outcomes
• Paying pharmacists for outcomes rather than transactions
• Credentialing and recognizing pharmacists alongside other healthcare providers
• Expanding reimbursement beyond today’s limited incident-to billing pathways
• Why payment policy must evolve alongside automation
AI may automate more of pharmacy’s transactional work. But it could also help prove the value pharmacists have been providing all along.
The question is whether healthcare will act on that evidence and create a meaningful payment pathway before it is too late.
Subscribe for candid conversations with the leaders shaping what comes next in healthcare.
